Question 1

Should nanocrystals be synthesised in-house or purchased?

Accepted Answer

It depends on whether particle properties form part of the research question. Commercial preparations offer batch consistency and save considerable time when the study is biological. Synthesising in-house is justified when emission profile, shell composition, size or coating must be varied deliberately, but it adds a materials chemistry project alongside the biology.

Question 2

Why does surface coating matter more than core composition?

Accepted Answer

Because the coating determines what the cell actually encounters. Final diameter, surface charge, colloidal stability in serum and nonspecific binding all follow from the coating and ligand chemistry, and a particle that performs well in buffer can aggregate or stick indiscriminately in culture medium. Coating also sets the spacing between emitter and target.

Question 3

How is valency controlled so one particle reports one target?

Accepted Answer

Through conjugation chemistry and stoichiometry rather than optimism. Limiting the conjugation ratio, purifying by size exclusion, and confirming the distribution by gel shift or single-particle counting all help. Multivalent probes crosslink receptors and change the very behaviour being measured, so evidence for valency belongs in the main thesis argument.

Question 4

How is blinking handled in single-particle tracking?

Accepted Answer

Blinking breaks trajectories, so analysis must either bridge gaps using a defined maximum dark interval or rely on particles engineered for suppressed blinking. Gap-bridging parameters shift measured diffusion coefficients, so they should be stated and their influence tested. Reporting trajectory length distributions alongside results lets a reader judge the linking.

Question 5

What toxicity controls does live-cell work require?

Accepted Answer

Viability and proliferation assays across the concentration and exposure range actually used, rather than at one convenient point, plus a coating-only control lacking the metal core where feasible. Ion release depends on shell integrity and illumination, so light-induced toxicity deserves separate testing whenever long acquisitions are planned.

Question 6

How is endosomal entrapment after delivery accounted for?

Accepted Answer

It is often the main obstacle for intracellular targets. Options include surface labelling that sidesteps the problem, delivery routes bypassing endocytosis, or escape chemistries, each carrying its own artefacts. Whichever is chosen, colocalisation with endosomal markers should be quantified rather than assumed, since trapped particles produce convincing but meaningless motion.

Question 7

What characterisation should accompany every batch?

Accepted Answer

At minimum, absorbance and emission spectra for size and purity, hydrodynamic diameter and zeta potential after coating, and a stability check in the medium being used. Recording these per batch makes later variation interpretable. Electron microscopy and emission yield measurement are worth adding when particles are synthesised rather than purchased.

Biotechnology

Biotechnology

Research Frontiers in Quantum Dot Cellular Imaging